393 related articles for article (PubMed ID: 16310890)
1. Guidelines for the control of glycopeptide-resistant enterococci in hospitals.
Cookson BD; Macrae MB; Barrett SP; Brown DF; Chadwick C; French GL; Hateley P; Hosein IK; Wade JJ;
J Hosp Infect; 2006 Jan; 62(1):6-21. PubMed ID: 16310890
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of the impact of colonization following hospital admission by glycopeptide-resistant Enterococci on mortality during a hospital outbreak.
Hautemanière A; Hunter PR; Diguio N; Albuisson E; Hartemann P
Am J Infect Control; 2009 Nov; 37(9):746-52. PubMed ID: 19556034
[TBL] [Abstract][Full Text] [Related]
3. Glycopeptide-resistant Enterococcus raffinosus in a haematology unit: an unusual cause of a nosocomial outbreak.
Samuel J; Coutinho H; Galloway A; Rennison C; Kaufmann ME; Woodford N
J Hosp Infect; 2008 Nov; 70(3):294-6. PubMed ID: 18783849
[No Abstract] [Full Text] [Related]
4. Vancomycin-resistant enterococci: mechanisms and clinical observations.
Gold HS
Clin Infect Dis; 2001 Jul; 33(2):210-9. PubMed ID: 11418881
[TBL] [Abstract][Full Text] [Related]
5. Glycopeptide-resistant enterococci: deciphering virulence, resistance and epidemicity.
Willems RJ; Bonten MJ
Curr Opin Infect Dis; 2007 Aug; 20(4):384-90. PubMed ID: 17609597
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin-resistant enterococci: implications for infection control.
Molyneux R; Chadwick C
Prof Nurse; 1997 Jun; 12(9):641-4. PubMed ID: 9248438
[TBL] [Abstract][Full Text] [Related]
7. [Glycopeptide-resistant Enterococcus outbreak in an ICU with simultaneous circulation of two different clones].
Delamare C; Lameloise V; Lozniewski A; Perrin M; Baudin C; Sellies J; Dumay M; Bemer M;
Pathol Biol (Paris); 2008; 56(7-8):454-60. PubMed ID: 18835105
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci.
Leclercq R
Clin Microbiol Infect; 2009 Mar; 15(3):224-31. PubMed ID: 19335370
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin resistant Enterococci in a tertiary care hospital in Mumbai.
De A; Bindlish A; Kumar S; Mathur M
Indian J Med Microbiol; 2009; 27(4):375-6. PubMed ID: 19736416
[No Abstract] [Full Text] [Related]
10. Control of a regional outbreak of vanA glycopeptide-resistant Enterococcus faecium, Eastern France, 2004-2009.
Henard S; Gendrin V; Simon L; Jouzeau N; Vernier N; Thiolet JM; Coignard B; Rabaud C
Int J Hyg Environ Health; 2011 Jun; 214(3):265-70. PubMed ID: 21330205
[TBL] [Abstract][Full Text] [Related]
11. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force.
Weber SG; Huang SS; Oriola S; Huskins WC; Noskin GA; Harriman K; Olmsted RN; Bonten M; Lundstrom T; Climo MW; Roghmann MC; Murphy CL; Karchmer TB
Am J Infect Control; 2007 Mar; 35(2):73-85. PubMed ID: 17327185
[TBL] [Abstract][Full Text] [Related]
12. Implementing guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: how valid are international comparisons of success?
Humphreys H
J Hosp Infect; 2006 Feb; 62(2):133-5. PubMed ID: 16337032
[No Abstract] [Full Text] [Related]
13. VRE--what every health care provider needs to know.
Mikos-Schild S
Todays Surg Nurse; 1998; 20(3):13-6; quiz 40-1. PubMed ID: 10026632
[TBL] [Abstract][Full Text] [Related]
14. [What is to be done with vancomycin-resistant enterococcal infections?].
Bonten MJ; Mascini EM; Willems R; Timmer GJ; Gaillard CA; Vandenbroucke-Grauls CM
Ned Tijdschr Geneeskd; 2000 Dec; 144(53):2545-9. PubMed ID: 11191789
[TBL] [Abstract][Full Text] [Related]
15. Debate-guidelines for control of glycopeptide-resistant enterococci (GRE) have not yet worked.
McGowan JE
J Hosp Infect; 2004 Aug; 57(4):281-4. PubMed ID: 15320355
[TBL] [Abstract][Full Text] [Related]
16. Healthcare-associated versus community-acquired infections: a new challenge for science and society.
Gastmeier P
Int J Med Microbiol; 2010 Aug; 300(6):342-5. PubMed ID: 20452277
[TBL] [Abstract][Full Text] [Related]
17. Significant increase in the isolation of glycopeptide-resistant enterococci from patients hospitalized in the transplant surgery ward in 2004-2005.
Młynarczyk G; Grzybowska W; Młynarczyk A; Tyski S; Kawecki D; Łuczak M; Chmura A; Rowiński W
Transplant Proc; 2007 Nov; 39(9):2883-5. PubMed ID: 18022008
[TBL] [Abstract][Full Text] [Related]
18. Managing vancomycin-resistant enterococci. A winning team approach.
Robinson K; Duff Z; Mercer J; Cran M; Gill-Morton P; Main S
Can Nurse; 1997 Nov; 93(10):36-9. PubMed ID: 9444145
[TBL] [Abstract][Full Text] [Related]
19. Optimizing therapy for vancomycin-resistant enterococci (VRE).
Linden PK
Semin Respir Crit Care Med; 2007 Dec; 28(6):632-45. PubMed ID: 18095227
[TBL] [Abstract][Full Text] [Related]
20. [Vancomycin resistant Enterococci (VRE)].
Lesens O
Nephrol Ther; 2009 Jun; 5 Suppl 4():S261-4. PubMed ID: 19596346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
